TipRanks
Ceryvyn Therapeutics Limited (DE:UKJ2)
MUNICH:UKJ2
Germany Market
UKJ2
Ceryvyn Therapeutics Limited
RESEARCH TOOLSreports

Ceryvyn Therapeutics Limited (UKJ2) Income Statement

0 Followers

Ceryvyn Therapeutics Limited Income Statement

Last quarter (Q4 2024), Ceryvyn Therapeutics Limited's total revenue was AU$89.39K, an increase of 35.24% from the same quarter last year. In Q4, Ceryvyn Therapeutics Limited's net income was AU$-185.99M. See Ceryvyn Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
AU$ 124.67KAU$ 161.16KAU$ 125.05KAU$ 91.98KAU$ 145.90K
Gross Profit
AU$ 21.72KAU$ -89.31KAU$ -107.42KAU$ -480.00KAU$ -371.37K
Operating Expenses
AU$ 191.97MAU$ 223.46MAU$ 133.29MAU$ 53.13MAU$ 24.71M
Depreciation and Amortization
AU$ 103.03KAU$ 150.49KAU$ 108.08KAU$ 143.00KAU$ 144.02K
EBITDA
AU$ -200.02MAU$ -223.30MAU$ -99.01MAU$ -50.14MAU$ -24.92M
Operating Income
AU$ -191.84MAU$ -223.45MAU$ -133.27MAU$ -53.18MAU$ -24.70M
Other Income/Expenses
AU$ -37.81MAU$ -70.67MAU$ -3.41MAU$ -14.23MAU$ 310.76K
Pretax Income
AU$ -229.65MAU$ -220.69MAU$ -136.68MAU$ -67.41MAU$ -24.39M
Net Income
AU$ -220.24MAU$ -211.88MAU$ -127.99MAU$ -60.79MAU$ -16.12M
Per Share Metrics
Basic EPS
AU$ -22.16AU$ -3.60AU$ -2.72AU$ -1.44AU$ -0.50
Diluted EPS
AU$ -22.16AU$ -3.60AU$ -2.72AU$ -1.44AU$ -0.49
Weighted Average Shares Outstanding
 79.78M 58.69M 46.62M 42.49M 32.56M
Weighted Average Shares Outstanding (Diluted)
 79.78M 58.69M 46.62M 42.49M 32.60M
Currency in AUD

Ceryvyn Therapeutics Limited Earnings and Revenue History